# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Highest-ever April ADV with 33% growth over April 2023 Record April ADV for interest rate, equity index, metals, FX and opti...
Barclays analyst Benjamin Budish maintains CME Gr (NASDAQ:CME) with a Equal-Weight and raises the price target from $226 to ...
B of A Securities analyst Craig Siegenthaler maintains CME Gr (NASDAQ:CME) with a Neutral and raises the price target from $...
JP Morgan analyst Kenneth Worthington maintains CME Gr (NASDAQ:CME) with a Neutral and raises the price target from $198 to ...
Keefe, Bruyette & Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:CME) with a Market Perform and raises the price targ...
Rosenblatt analyst Andrew Bond reiterates CME Gr (NASDAQ:CME) with a Sell and raises the price target from $185 to $187.
Rising Treasury yields have investors cautious despite positive news from the earnings season. The yield on the long-dated 3...